CN1311843C - Chinese herbal medicinal preparation for treating hyperosteogeny - Google Patents

Chinese herbal medicinal preparation for treating hyperosteogeny Download PDF

Info

Publication number
CN1311843C
CN1311843C CNB2005100967330A CN200510096733A CN1311843C CN 1311843 C CN1311843 C CN 1311843C CN B2005100967330 A CNB2005100967330 A CN B2005100967330A CN 200510096733 A CN200510096733 A CN 200510096733A CN 1311843 C CN1311843 C CN 1311843C
Authority
CN
China
Prior art keywords
portions
treatment
present
mode
hyperosteogeny
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100967330A
Other languages
Chinese (zh)
Other versions
CN1736408A (en
Inventor
李正发
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100967330A priority Critical patent/CN1311843C/en
Publication of CN1736408A publication Critical patent/CN1736408A/en
Application granted granted Critical
Publication of CN1311843C publication Critical patent/CN1311843C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention provides a traditional Chinese herbal medicinal preparation for treating hyperosteogeny, which mainly contains 1 portion of herba speranskiae tuberculatae, 1 to 3 portions of forrest silkvine stem or root, 3 to 5 portions of centipede and 3 to 5 portions of scorpion. The present invention is a powdery mixture, and can also contain 0.5 to 1.5 portions of fineleaf schizonepeta herb or/and 3 to 5 portions of Chinese clematis, wherein the herba speranskiae tuberculatae, the forrest silkvine stem or root, the fineleaf schizonepeta herb and the Chinese clematis are powder made from crystal paste extracted in the mode of boiling extraction, extraction by a concentration mode or extraction by an alcohol mode. The dosage form of the mixture is a capsule or a tablet. The present invention has the characteristics of fast effect taking on the treatment of hyperosteogeny disease, stable therapeutic effect, no toxic or side effect, no recurrence or low relapse rate after recovery and low production cost; effect is taken within 1 to 3 days or even in the same day, the relapse rate is from 8 to 12%, and the excellence rate is 100%; compared with the production cost of the existing bark scorpion capsules, the production cost is reduced by more than 30%. The present invention also has therapeutic effects on gout and rheumatism.

Description

A kind of Chinese herbal and crude drugs preparations for the treatment of hyperosteogeny
Technical field the invention belongs to a kind of Chinese herbal and crude drugs preparations for the treatment of hyperosteogeny.
The background technology hyperosteogeny is the commonly encountered diseases frequently-occurring disease of modern society, owing to outgrowth sclerotin pressuring nerve makes the patient dizziness and blurred vision, myasthenia of limbs, a waist occur can not the side commentaries on classics, symptom such as paralysis, serious entail dangers to life.Though the medicine of existing treatment hyperosteogeny disease is many, but all there is the curative effect deficiency, problems such as treatment time is long, such as the Muxie capsule of selling on present market effect to some extent just more than the prolapse of lumbar intervertebral disc that treatment is caused by hyperosteogeny is generally wanted medication half a year, curative effect can not be satisfactory, production cost is also than higher, and is bigger to patient's economic pressures.
The Chinese herbal and crude drugs preparations of the treatment hyperosteogeny that summary of the invention the objective of the invention is to propose not recur after a kind of rapid-action, stable curative effect, the rehabilitation or relapse rate is low, short treating period and production cost are low is to solve
The deficiencies in the prior art.
The Chinese herbal and crude drugs preparations of this treatment hyperosteogeny that the present invention proposes is characterized in that it mainly contains by weight 1 part of Herba speranskiae tuberculatae, Caulis et Radix Periplocae Forrestii 1-3 part, Scolopendra 3-5 part, Scorpio 3-5 part, is powder mixture.
Also can contain Herba Schizonepetae 0.5-1.5 part or/and Radix Clematidis 3-5 part.
Wherein, Herba speranskiae tuberculatae, Caulis et Radix Periplocae Forrestii, Herba Schizonepetae and/or Radix Clematidis are to carry, concentrate the powder that brilliant cream that mode or ethanol mode extract is made, these powder and Scolopendra powder, Scorpio powder mix homogeneously by boiling.
The dosage form of mixture is capsule or tablet.
Characteristics of the present invention are rapid-action to the treatment hyperosteogeny disease, take effect even onset on the same day stable curative effect in 1-3 days, have no side effect, do not recur after the rehabilitation or relapse rate low, can be controlled at 8-12%, obvious effective rate 100%, production cost is low, and is lower more than 30% than existing Muxie capsule.The present invention is also effective in cure to gout and rheumatism.
Use example in detail the present invention below.
Specific embodiment case 1 Zhu, woman, 40 years old (age during morbidity, down together), Han nationality, people from Qujing, Yunnan, certain corpsman,hospital.Playing the beginning pain in the lumbar region in January, 1993, is third and fourth joint hypertrophy of lumbar vertebra through taking the photograph the sheet inspection, and patient is waist not directly, pain unbearably, though lose effect through multi-treatment.Begin to treat with medicament capsule of the present invention in June, 1994, with 15 days be a course of treatment, rehabilitation after three courses of treatment, not recurrence so far.According to patient's private prosecution, the same day pain of taking medicine promptly obviously alleviates.The concrete combination prescription of this example is 1 part of Herba speranskiae tuberculatae, 1 part of Caulis et Radix Periplocae Forrestii, 3 parts of Scolopendras, 3 parts of Scorpios, is powder mixture, and every capsules contains powder mixture 0.4 gram.Wherein Herba speranskiae tuberculatae, Caulis et Radix Periplocae Forrestii are the brilliant cream powder that aforesaid way extracts.Method of administration is three times, each three of day clothes.
Case 2 kings so-and-so, woman, 35 years old, Han nationality, people from Qujing, Yunnan, peasant.Be lumbar vertebra third and fourth joint hypertrophy through looking in May, 2000, the same substantially example of the state of an illness, patient's pain degree again on example serious.Lose effect through treatment with western, patient is still still painful.Begin to treat with medicine of the present invention March calendar year 2001, is almost recovered after the course of treatment, returns to one's perfect health after two courses of treatment, do not see recurrence so far.The concrete prescription of this example is 1 part of Herba speranskiae tuberculatae, 3 parts of Caulis et Radix Periplocae Forrestiis, 5 parts of Scolopendras, 5 parts of Scorpios.The same example of all the other situations.
Case 3 Lee so-and-so, man, 37 years old, Han nationality, people from Kunming, Yunnan, certain company manager.Before 8 years, dizziness, tinnitus, dim eyesight are often arranged, rotary head and symptom such as pain very when coming back are looked into and are hyperosteogeny of cervical vertebra, though eaten the various rare Chinese medicines and the Western medicine of hundreds of thousands, wherein also comprise above-mentioned Muxie capsule, all do not obtain positive effect.The year before, take medicine of the present invention and treat, be rehabilitation two courses of treatment, and the new line rotary head nimbly and freely.Patient is very grateful to this, indicates heavily to thank the inventor again and again.This routine medicament composing prescription is 1 part of Herba speranskiae tuberculatae, 2 parts of Caulis et Radix Periplocae Forrestiis, 4 parts of Scolopendras, 4 parts of Scorpios.The same example of all the other situations.
Case 4 Guo so-and-so, the woman, 53 years old, Han nationality, Qujing, Yunnan Malong County peasant suffered from hyperosteogeny of cervical vertebra in 1985.Fall ill often with dizziness, cerebral blood supply insufficiency, dim eyesight, general weakness, head can't side change, and also lifts and does not start.Many effect of drugs are not obvious with crossing, and pain still.August nineteen ninety, adopt medicine begin treatment of the present invention, be basic rehabilitation two courses of treatment, returns to one's perfect health after the course of treatment of continuing to take medicine, symptom disappears entirely.This routine prescription is 1 part of Herba speranskiae tuberculatae, 2 parts of Caulis et Radix Periplocae Forrestiis, 4 parts of Scolopendras, 4 parts of Scorpios, Herba Schizonepetae 0.5-1.5 part.Introduce through this routine patient, suffer from similar disease, the people successively treats with this routine medicine surplus the close patient 30 of symptom, has obtained satisfied effect equally, and be that 2-3 is individual the course of treatment.The same example of all the other situations.Replace Herba Schizonepetae with 3-5 part Radix Clematidis, all the other are constant, and on probation to three patients that symptom is similar, effect is suitable.
Case 5 kings so-and-so, the man, 35 years old, Han nationality, Kunming Railway Bureau driver, find to suffer from lumbar vertebra hyperosteogeny in January, 2003, look into and be that third and fourth joint lumbar vertebra hyperosteogeny, symptom are lumbago, directly not waist, compressing sciatic nerve pain, can not top bar when serious on foot, trick is ineffective, and it is very dangerous to drive.Through multi-treatment, DeGrain.Begin to take medicament capsule of the present invention in October, 2003, transference cure after four courses of treatment is taken the photograph the sheet inspection and is confirmed, the affected area sclerotin has stopped increasing.This routine medicament composing prescription is 1 part of Herba speranskiae tuberculatae, 2 parts of Caulis et Radix Periplocae Forrestiis, 4 parts of Scolopendras, 4 parts of Scorpios, Herba Schizonepetae 0.5-1.5 part, 4 parts of Radix Clematidis.Treat with the patient name surplus 10 with this routine medicine the back, all obtains promising result, and except that Radix Clematidis content changed between 3-5 part, all the other were constant, and promptly heal 2-3 the course of treatment.
Case 6 Lee so-and-so, the man, 32 years old, Han nationality, people from Qujing, Yunnan, the cadre, it is crazy that in December, 2004 is suffered from acute pain, the foot congestion and swelling pain takes 7 day time usually and could effectively cure with the conventional method treatment of having an injection.Take the medicine identical and treat with example 5, day clothes three times, each 3-4 grain, focus promptly disappeared in three days.
This routine medicine is through trying out obvious effective rate 89% to 12 rheumatic sufferers.
The tablet made from equal composition dosage, through 6 disease patients identical with above-mentioned 6 cases are treated, instructions of taking, dosage are same, and effect is identical.

Claims (3)

1, a kind of Chinese herbal and crude drugs preparations for the treatment of hyperosteogeny, it is characterized in that it is made up of 1 part of Herba speranskiae tuberculatae, Caulis et Radix Periplocae Forrestii 1-3 part, Scolopendra 3-5 part, Scorpio 3-5 part of weight meter, be powder mixture, wherein the powder made for the brilliant cream of putting forward, concentrating mode or ethanol mode by boiling and extract of Herba speranskiae tuberculatae and Caulis et Radix Periplocae Forrestii.
2, the Chinese herbal and crude drugs preparations of treatment hyperosteogeny according to claim 1 is characterized in that also containing Herba Schizonepetae 0.5-1.5 part or/and the passing through to boil and carry, concentrate the powder that brilliant cream that mode or ethanol mode extract is made of Radix Clematidis 3-5 part.
3, the Chinese herbal and crude drugs preparations of treatment hyperosteogeny according to claim 1 and 2, the dosage form that it is characterized in that mixture is capsule or tablet.
CNB2005100967330A 2005-03-29 2005-08-23 Chinese herbal medicinal preparation for treating hyperosteogeny Expired - Fee Related CN1311843C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100967330A CN1311843C (en) 2005-03-29 2005-08-23 Chinese herbal medicinal preparation for treating hyperosteogeny

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200510010725 2005-03-29
CN200510010725.X 2005-03-29
CNB2005100967330A CN1311843C (en) 2005-03-29 2005-08-23 Chinese herbal medicinal preparation for treating hyperosteogeny

Publications (2)

Publication Number Publication Date
CN1736408A CN1736408A (en) 2006-02-22
CN1311843C true CN1311843C (en) 2007-04-25

Family

ID=36079480

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100967330A Expired - Fee Related CN1311843C (en) 2005-03-29 2005-08-23 Chinese herbal medicinal preparation for treating hyperosteogeny

Country Status (1)

Country Link
CN (1) CN1311843C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108524573A (en) * 2018-07-03 2018-09-14 徐斌 Chinese medicine composition for treating muscles and bones disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1298727A (en) * 2000-12-14 2001-06-13 张子生 Plaster for treating hyperosteogeny
CN1304738A (en) * 2000-12-30 2001-07-25 王连俊 Quick-acting plaster for treating rheumatic arthritis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1298727A (en) * 2000-12-14 2001-06-13 张子生 Plaster for treating hyperosteogeny
CN1304738A (en) * 2000-12-30 2001-07-25 王连俊 Quick-acting plaster for treating rheumatic arthritis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
中西医结合非手术综合疗法治疗腰椎间盘突出症 张运等,云南中医中药杂志,第20卷第3期 1999 *

Also Published As

Publication number Publication date
CN1736408A (en) 2006-02-22

Similar Documents

Publication Publication Date Title
CN102228485B (en) Composition for burn rehabilitation and preparation method thereof
CN104138550A (en) Preparation method of medicine for treating peptic ulcers
CN103961424A (en) Traditional Chinese medicine formula for treating cervical spondylosis and preparation method of traditional Chinese medicine capsule preparation
CN110898201B (en) A topical Chinese medicinal composition for removing food stagnation in children, and its preparation method
CN103330837B (en) Traditional Chinese medicine composition for curing osteoporosis of menopausal women
CN1311843C (en) Chinese herbal medicinal preparation for treating hyperosteogeny
CN102258670A (en) Medicine for treating calcaneodynia
CN104706839A (en) Traditional Chinese medicine preparation for treating rheumatic arthritis
CN104857188A (en) Traditional Chinese medicine composite for treating edema
CN104474108A (en) Traditional Chinese medicine preparation for treating acute appendicitis and preparation method of traditional Chinese medicine preparation
CN108671165A (en) A kind of traditional Chinese herbal decoction for treating female climacteric syndrome
CN105311140A (en) Pharmaceutical composition for treating cervical spondylosis and preparation method thereof
CN105311210A (en) Pharmaceutical composition for treating rheumatoid bone diseases
CN103751624B (en) A kind of medicine and preparation method for the treatment of numb limbs and tense tendons after apoplexy
CN102125648B (en) Medicament for treating hyperosteogeny and preparation method thereof
CN106074992A (en) A kind of medical herbs for oral administration treating chest traumatic injury wound and using method thereof
CN101229255A (en) Chinese traditional medicine formulation for treating acute waist injury
CN105663850A (en) Traditional Chinese medicine composition for treating oral ulcer
CN105920229A (en) Traditional Chinese medicine composition for treating acute ankle sprain
CN105943639A (en) Traditional Chinese medicine composition assisting in treating chronic subdural hematoma
CN105596651B (en) A kind of Chinese medicinal plaster and preparation method thereof for treating vertebral artery type of cervical spondylosis
CN105560537A (en) Medicine composition for treating osteoartritis and preparation method thereof
CN105125988A (en) Traditional Chinese medicinal preparation for treating thromboangiitis obliterans and preparation method of traditional Chinese medicinal preparation
CN105168973A (en) Traditional Chinese medicine for treating cervical spondylosis and lumbar spondylosis
CN104189083A (en) Chinese herbal preparation for treating acute maxillary sinusitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070425

Termination date: 20130823